source
- Expedition Therapeutics raises $115M Series B for China-sourced COPD candidateExpedition Therapeutics, a US biotech, announced a $115 million Series B financing round. The capital will be used to advance its COPD drug candidate that is being developed from a China-sourced p…
- WuXi AppTec posts six-month revenue higher than Lonza for first timeWuXi AppTec, a Chinese contract manufacturing organization, has reported that its revenue over the most recent six-month period exceeded that of Swiss CDMO Lonza for the first time. The increase c…